{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:43:38Z","timestamp":1793400218546,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0725-7","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T17:35:13Z","timestamp":1419960913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Claudio","family":"Viscoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,31]]},"reference":[{"issue":"9","key":"725_CR1","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.1371\/journal.pone.0024198","volume":"6","author":"M Bassetti","year":"2011","unstructured":"Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C: Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One. 2011, 6 (9): e24198-10.1371\/journal.pone.0024198.","journal-title":"PLoS One"},{"issue":"9","key":"725_CR2","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1128\/JCM.00179-11","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK: Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011, 49 (9): 3300-3308. 10.1128\/JCM.00179-11.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"725_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10096-006-0159-2","volume":"25","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Apostolou KE, Pappas VD: Attributable mortality of candidemia: a systematic review of matched cohort and case\u2013control studies. Eur J Clin Microbiol Infect Dis. 2006, 25 (7): 419-425. 10.1007\/s10096-006-0159-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"725_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003, 37 (9): 1172-1177. 10.1086\/378745.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"725_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/502581","volume":"26","author":"J Morgan","year":"2005","unstructured":"Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM: Excess mortality, hospital stay, and cost due to candidemia: a case\u2013control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005, 26 (6): 540-547. 10.1086\/502581.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"725_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","volume":"55","author":"AM Tortorano","year":"2012","unstructured":"Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, Cavanna C, Marino G, Morero S, Ossi C, Delvecchio G, Passera M, Cusumano V, David A, Bonaccorso G, Corona A, Favaro M, Vismara C, Garau MG, Falchi S, Tejada MR, ECMM-FIMUA Study Group: Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008). Mycoses. 2012, 55 (1): 73-79. 10.1111\/j.1439-0507.2011.02044.x.","journal-title":"Mycoses"},{"issue":"21","key":"725_CR7","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. Jama. 2009, 302 (21): 2323-2329. 10.1001\/jama.2009.1754.","journal-title":"Jama"},{"issue":"1","key":"725_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1542\/peds.2004-2292","volume":"117","author":"DK Benjamin Jr","year":"2006","unstructured":"Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R: Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22\u00a0months. Pediatrics. 2006, 117 (1): 84-92. 10.1542\/peds.2004-2292.","journal-title":"Pediatrics"},{"issue":"4","key":"725_CR9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","volume":"42","author":"RA Hajjeh","year":"2004","unstructured":"Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW: Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004, 42 (4): 1519-1527. 10.1128\/JCM.42.4.1519-1527.2004.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"725_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/jac\/dki258","volume":"56","author":"K Laupland","year":"2005","unstructured":"Laupland K, Gregson D, Church D, Ross T, Elsayed S: Invasive Candida species infections: a 5\u00a0year population-based assessment. J Antimicrob Chemother. 2005, 56 (3): 532-537. 10.1093\/jac\/dki258.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 7","key":"725_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Fl\u00f6rl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012, 18 (Suppl 7): 19-37. 10.1111\/1469-0691.12039.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"725_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1469-0691.12040","volume":"18","author":"WW Hope","year":"2012","unstructured":"Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Fl\u00f6rl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012, 18 (Suppl 7): 38-52. 10.1111\/1469-0691.12040.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"725_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/1469-0691.12041","volume":"18","author":"AJ Ullmann","year":"2012","unstructured":"Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Fl\u00f6rl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M, ESCMID Fungal Infection Study Group: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 2012, 18 (Suppl 7): 53-67. 10.1111\/1469-0691.12041.","journal-title":"Clin Microbiol Infect"},{"key":"725_CR14","unstructured":"European Medicines Agency (EMA): Mycamine\u00ae: EPAR - Product Information [http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000734\/WC500031075.pdf]"},{"issue":"9572","key":"725_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","volume":"369","author":"ER Kuse","year":"2007","unstructured":"Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA, Micafungin Invasive Candidiasis Working Group: Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet. 2007, 369 (9572): 1519-1527. 10.1016\/S0140-6736(07)60605-9.","journal-title":"Lancet"},{"issue":"10","key":"725_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","volume":"24","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN: International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis. 2005, 24 (10): 654-661. 10.1007\/s10096-005-0024-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"725_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1086\/520980","volume":"45","author":"PG Pappas","year":"2007","unstructured":"Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN: Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007, 45 (7): 883-893. 10.1086\/520980.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"725_CR18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","volume":"27","author":"F Queiroz-Telles","year":"2008","unstructured":"Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, Konja J, Diekmann-Berndt H, Koblinger S, Groll AH, Arrieta A, Micafungin Invasive Candidiasis Study Group: Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008, 27 (9): 820-826. 10.1097\/INF.0b013e31817275e6.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"725_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mu\u00f1oz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, et al: Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008, 46 (12): 1813-1821. 10.1086\/588660.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"725_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE: Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and European organization for research and treatment of cancer consensus criteria. Clin Infect Dis. 2008, 47 (5): 674-683. 10.1086\/590566.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"725_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","volume":"165","author":"DK Wysowski","year":"2005","unstructured":"Wysowski DK, Swartz L: Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions. Arch Intern Med. 2005, 165 (12): 1363-1369. 10.1001\/archinte.165.12.1363.","journal-title":"Arch Intern Med"},{"issue":"2","key":"725_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/14740338.2011.557062","volume":"10","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Pappas PG, Young JA, Maddison P, Ullmann AJ: Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases. Expert opinion on drug safety. 2011, 10 (2): 171-183. 10.1517\/14740338.2011.557062.","journal-title":"Expert opinion on drug safety"},{"issue":"9390","key":"725_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW: Echinocandin antifungal drugs. Lancet. 2003, 362 (9390): 1142-1151. 10.1016\/S0140-6736(03)14472-8.","journal-title":"Lancet"},{"issue":"6","key":"725_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ijantimicag.2011.07.008","volume":"38","author":"AL Ngai","year":"2011","unstructured":"Ngai AL, Bourque MR, Lupinacci RJ, Strohmaier KM, Kartsonis NA: Overview of safety experience with caspofungin in clinical trials conducted over the first 15\u00a0years: a brief report. Int J Antimicrob Agents. 2011, 38 (6): 540-544. 10.1016\/j.ijantimicag.2011.07.008.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"725_CR25","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.01657-09","volume":"54","author":"JL Wang","year":"2010","unstructured":"Wang JL, Chang CH, Young-Xu Y, Chan KA: Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Antimicrob Agents Chemother. 2010, 54 (6): 2409-2419. 10.1128\/AAC.01657-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"725_CR26","unstructured":"Astellas Pharma US: Mycamine (micafungin sodium) for injection: US prescribing information (online) [http:\/\/www.astellas.us\/docs\/mycamine.pdf]"},{"issue":"2","key":"725_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/jac\/dkr494","volume":"67","author":"JM Julius","year":"2012","unstructured":"Julius JM, Gaikwad A, Lowry A, Lewis RE, Lozano RD, Dalrymple JL, Coleman RL, Smith JA: Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. J Antimicrob Chemother. 2012, 67 (2): 422-429. 10.1093\/jac\/dkr494.","journal-title":"J Antimicrob Chemother"},{"key":"725_CR28","doi-asserted-by":"crossref","unstructured":"Palazzi DL, Arrieta A, Castagnola E, Halasa N, Hubbard S, Brozovich AA, Fisher BT, Steinbach WJ: Candida Speciation, Antifungal Treatment, and Adverse Events in Pediatric Invasive Candidiasis: Results from 441 Infections in a Prospective, Multi-National Study. Pediatr Infect Dis J 2014, 33(12):1294-1296","DOI":"10.1097\/INF.0000000000000431"},{"issue":"12","key":"725_CR29","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","volume":"31","author":"WJ Steinbach","year":"2012","unstructured":"Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, Palazzi DL, Castagnola E, Halasa N, Velegraki A, Dvorak CC, Charkabarti A, Sung L, Danziger-Isakov L, Lachenauer C, Arrieta A, Knapp K, Abzug MJ, Ziebold C, Lehrnbecher T, Klingspor L, Warris A, Leckerman K, Martling T, Walsh TJ, Benjamin DK, Zaoutis TE, International Pediatric Fungal Network: Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012, 31 (12): 1252-1257. 10.1097\/INF.0b013e3182737427.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0725-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0725-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:06:43Z","timestamp":1630566403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0725-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0725-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"15 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"725"}}